Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study
- PMID: 30657926
- PMCID: PMC6792072
- DOI: 10.1093/jnci/djz001
Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study
Abstract
Background: Black-white differences in smoking abstinence are not well understood. This trial sought to confirm previously reported differences in quitting between blacks and whites and to identify factors underlying this difference.
Methods: During enrollment, 224 black and 225 white low-income smokers were stratified on race and within race on age and sex to ensure balance on these factors known to impact abstinence. The intervention included varenicline for 12 weeks and six guideline-based smoking cessation counseling sessions. The primary endpoint was cotinine-verified 7-day point prevalence smoking abstinence at week 26. A priori socioeconomic, smoking, treatment process (eg, treatment utilization, side effects, withdrawal relief), psychosocial, and biological factors were assessed to investigate race differences in abstinence. Unadjusted odds ratios (OR) were used to compare abstinence between blacks and whites. Adjusted odds ratios from logistic regression models were used to examine predictors of abstinence. All statistical tests were two-sided.
Results: Blacks were less likely to achieve abstinence at week 26 (14.3% vs 24.4%, OR = 0.51, 95% confidence interval [CI] = 0.32 to 0.83, P = .007). Utilizing best subsets logistic regression, five factors associated with race jointly predicted abstinence: home ownership (yes/no, OR = 3.03, 95% CI = 1.72 to 5.35, P < .001), study visits completed (range = 0-6, OR = 2.81, 95% CI = 1.88 to 4.20, P < .001), income (household member/$1000, OR = 1.03, 95% CI = 1.01 to 1.06, P = .02), plasma cotinine (per 1 ng/mL, OR = 0.997, 95% CI = 0.994 to 0.999, P = .002), and neighborhood problems (range = 10-30, OR = 0.88, 95% CI = 0.81 to 0.96, P = .003).
Conclusions: The race difference in abstinence was fully explained by lack of home ownership, lower income, greater neighborhood problems, higher baseline cotinine, and higher visit completion, which were disproportionately represented among blacks. Findings illuminate factors that make it harder for blacks in the United States to quit smoking relative to whites and provide important areas for future studies to reduce tobacco-related health disparities.
Trial registration: ClinicalTrials.gov NCT01836276.
© The Author, 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Engagement and Short-term Abstinence Outcomes Among Blacks and Whites in the National Cancer Institute's SmokefreeTXT Program.Nicotine Tob Res. 2020 Aug 24;22(9):1622-1626. doi: 10.1093/ntr/ntz178. Nicotine Tob Res. 2020. PMID: 31535690 Free PMC article.
-
A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.Contemp Clin Trials. 2016 Mar;47:12-21. doi: 10.1016/j.cct.2015.12.001. Epub 2015 Dec 5. Contemp Clin Trials. 2016. PMID: 26667382 Free PMC article. Clinical Trial.
-
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.Oncologist. 2016 Jan;21(1):40-9. doi: 10.1634/theoncologist.2015-0325. Epub 2015 Dec 28. Oncologist. 2016. PMID: 26712960 Free PMC article. Clinical Trial.
-
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.
-
Myeloma and race: a review of the literature.Cancer Metastasis Rev. 2003 Mar;22(1):87-93. doi: 10.1023/a:1022268103136. Cancer Metastasis Rev. 2003. PMID: 12716040 Review.
Cited by
-
The co-occurrence of smoking and alcohol use disorder in a hospital-based population: Applying a multimorbidity framework using geographic information system methods.Addict Behav. 2021 Jul;118:106883. doi: 10.1016/j.addbeh.2021.106883. Epub 2021 Feb 26. Addict Behav. 2021. PMID: 33714034 Free PMC article.
-
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.Clin Pharmacol Ther. 2021 Oct;110(4):975-985. doi: 10.1002/cpt.2135. Epub 2021 Jan 1. Clin Pharmacol Ther. 2021. PMID: 33300144 Free PMC article.
-
Operationalizing the Population Health Framework: Clinical Characteristics, Social Context, and the Built Environment.Popul Health Manag. 2021 Aug;24(4):454-462. doi: 10.1089/pop.2020.0170. Epub 2020 Oct 13. Popul Health Manag. 2021. PMID: 34406088 Free PMC article.
-
Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.Addict Neurosci. 2023 Sep;7:100083. doi: 10.1016/j.addicn.2023.100083. Epub 2023 Apr 1. Addict Neurosci. 2023. PMID: 37602286 Free PMC article.
-
The effect of area-level disadvantage and race on smoking abstinence in a clinical trial.Exp Clin Psychopharmacol. 2022 Jun;30(3):279-286. doi: 10.1037/pha0000493. Epub 2021 Aug 9. Exp Clin Psychopharmacol. 2022. PMID: 34370500 Free PMC article. Clinical Trial.
References
-
- US Department of Health and Human Services. The Health Consequences of Smoking–50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2014.
-
- Jamal A, King BA, Neff LJ et al. . Current cigarette smoking among adults - United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;6544:1205–1211. - PubMed
-
- US National Cancer Institute. A socioecological approach to addressing tobacco related health disparities. In: National Cancer Institute Tobacco Control Monograph 22. NIH Publication No. 17-CA-8035A. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2017.